Discovery Could Keep Bad Stem Cells Out of Therapies
Tuesday, April 23, 2013
Some pluripotent stem cells fail to differentiate and end up mixed in with their newly differentiated daughter cells.
UTSW Researchers Identify New Potential Target for Cancer Therapy
Monday, April 22, 2013
Researchers have found that alternative splicing – a process that allows a single gene to code for multiple proteins – appears to be a new potential target for anti-telomerase cancer therapy.
SCT Licenses Exclusive Rights to Clinical Cancer Stem Cell Program
Friday, April 19, 2013
Corporate refocusing mission completed.
Gene Found that Regenerates Heart Tissue
Thursday, April 18, 2013
UT Southwestern researchers identify gene that regenerates
heart tissue – critical finding for heart failure prevention.
Rigid Growth Matrix: A Key to Success of Cardiac Tissue Engineering
Monday, April 15, 2013
UCLA team found that rigid matrices promotes the generation of more cardiomyocytes cells from ES cells.
Results from C3BS C-CURE® Trial Published in the Journal of the ACC
Monday, April 15, 2013
Trial demonstrates statistically significant improvements in heart function and exercise tolerance with cardiopoietic stem cell therapy.
Thermo Fisher Scientific to Acquire Life Technologies Corporation
Monday, April 15, 2013
The definitive agreement will see Thermo Fisher will acquire Life Technologies for $76.00 in cash per fully diluted common share or approximately $13.6 billion.
Life Technologies Acquires KDR Biotech
Friday, April 12, 2013
The acquisition is part of Life Technologies strategic international growth plan in fast-growing markets.
LifeMap Sciences Adds Products through Partnership with ProSpec-Tany TechnoGene
Thursday, April 11, 2013
BioTime Subsidiary offers 100 select recombinant proteins in its BioReagents Portal.
|
|
|
| << | 1 2 3 4 5 6 7 | >> | | Showing Results 31 - 40 of 1778 |
|
|
